Red biotechnology is also known as biopharmaceuticals. It involves the application of biotechnology to produce medicine and drugs.
Scope of the Report:
The global Red Biotechnology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Red Biotechnology.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Red Biotechnology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Red Biotechnology market by product type and applications/end industries.
Market Segment by Companies, this report covers
F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibody
Nucleic Acid
Protein
Other
Market Segment by Applications, can be divided into
Biopharmaceutical Production
Gene Therapy
Pharmacogenomics and Genetic Testing
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Red Biotechnology Market Overview
1.1 Product Overview and Scope of Red Biotechnology
1.2 Classification of Red Biotechnology by Types
1.2.1 Global Red Biotechnology Revenue Comparison by Types (2019-2024)
1.2.2 Global Red Biotechnology Revenue Market Share by Types in 2018
1.2.3 Antibody
1.2.4 Nucleic Acid
1.2.5 Protein
1.2.6 Other
1.3 Global Red Biotechnology Market by Application
1.3.1 Global Red Biotechnology Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Biopharmaceutical Production
1.3.3 Gene Therapy
1.3.4 Pharmacogenomics and Genetic Testing
1.4 Global Red Biotechnology Market by Regions
1.4.1 Global Red Biotechnology Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Red Biotechnology Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Red Biotechnology Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Red Biotechnology Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Red Biotechnology Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Red Biotechnology Status and Prospect (2014-2024)
1.5 Global Market Size of Red Biotechnology (2014-2024)
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 Business Overview
2.1.2 Red Biotechnology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Red Biotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Red Biotechnology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Red Biotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.3 Gilead Sciences
2.3.1 Business Overview
2.3.2 Red Biotechnology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Gilead Sciences Red Biotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.4 CSL
2.4.1 Business Overview
2.4.2 Red Biotechnology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CSL Red Biotechnology Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Red Biotechnology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Red Biotechnology Revenue, Gross Margin and Market Share (2017-2018)
3 Global Red Biotechnology Market Competition, by Players
3.1 Global Red Biotechnology Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Red Biotechnology Players Market Share
3.2.2 Top 10 Red Biotechnology Players Market Share
3.3 Market Competition Trend
4 Global Red Biotechnology Market Size by Regions
4.1 Global Red Biotechnology Revenue and Market Share by Regions
4.2 North America Red Biotechnology Revenue and Growth Rate (2014-2019)
4.3 Europe Red Biotechnology Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Red Biotechnology Revenue and Growth Rate (2014-2019)
4.5 South America Red Biotechnology Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Red Biotechnology Revenue and Growth Rate (2014-2019)
5 North America Red Biotechnology Revenue by Countries
5.1 North America Red Biotechnology Revenue by Countries (2014-2019)
5.2 USA Red Biotechnology Revenue and Growth Rate (2014-2019)
5.3 Canada Red Biotechnology Revenue and Growth Rate (2014-2019)
5.4 Mexico Red Biotechnology Revenue and Growth Rate (2014-2019)
6 Europe Red Biotechnology Revenue by Countries
6.1 Europe Red Biotechnology Revenue by Countries (2014-2019)
6.2 Germany Red Biotechnology Revenue and Growth Rate (2014-2019)
6.3 UK Red Biotechnology Revenue and Growth Rate (2014-2019)
6.4 France Red Biotechnology Revenue and Growth Rate (2014-2019)
6.5 Russia Red Biotechnology Revenue and Growth Rate (2014-2019)
6.6 Italy Red Biotechnology Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Red Biotechnology Revenue by Countries
7.1 Asia-Pacific Red Biotechnology Revenue by Countries (2014-2019)
7.2 China Red Biotechnology Revenue and Growth Rate (2014-2019)
7.3 Japan Red Biotechnology Revenue and Growth Rate (2014-2019)
7.4 Korea Red Biotechnology Revenue and Growth Rate (2014-2019)
7.5 India Red Biotechnology Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Red Biotechnology Revenue and Growth Rate (2014-2019)
8 South America Red Biotechnology Revenue by Countries
8.1 South America Red Biotechnology Revenue by Countries (2014-2019)
8.2 Brazil Red Biotechnology Revenue and Growth Rate (2014-2019)
8.3 Argentina Red Biotechnology Revenue and Growth Rate (2014-2019)
8.4 Colombia Red Biotechnology Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Red Biotechnology by Countries
9.1 Middle East and Africa Red Biotechnology Revenue by Countries (2014-2019)
9.2 Saudi Arabia Red Biotechnology Revenue and Growth Rate (2014-2019)
9.3 UAE Red Biotechnology Revenue and Growth Rate (2014-2019)
9.4 Egypt Red Biotechnology Revenue and Growth Rate (2014-2019)
9.5 Nigeria Red Biotechnology Revenue and Growth Rate (2014-2019)
9.6 South Africa Red Biotechnology Revenue and Growth Rate (2014-2019)
10 Global Red Biotechnology Market Segment by Type
10.1 Global Red Biotechnology Revenue and Market Share by Type (2014-2019)
10.2 Global Red Biotechnology Market Forecast by Type (2019-2024)
10.3 Antibody Revenue Growth Rate (2014-2024)
10.4 Nucleic Acid Revenue Growth Rate (2014-2024)
10.5 Protein Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Red Biotechnology Market Segment by Application
11.1 Global Red Biotechnology Revenue Market Share by Application (2014-2019)
11.2 Red Biotechnology Market Forecast by Application (2019-2024)
11.3 Biopharmaceutical Production Revenue Growth (2014-2019)
11.4 Gene Therapy Revenue Growth (2014-2019)
11.5 Pharmacogenomics and Genetic Testing Revenue Growth (2014-2019)
12 Global Red Biotechnology Market Size Forecast (2019-2024)
12.1 Global Red Biotechnology Market Size Forecast (2019-2024)
12.2 Global Red Biotechnology Market Forecast by Regions (2019-2024)
12.3 North America Red Biotechnology Revenue Market Forecast (2019-2024)
12.4 Europe Red Biotechnology Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Red Biotechnology Revenue Market Forecast (2019-2024)
12.6 South America Red Biotechnology Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Red Biotechnology Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Red Biotechnology Picture
Table Product Specifications of Red Biotechnology
Table Global Red Biotechnology and Revenue (Million USD) Market Split by Product Type